The Future of the Aging Eye
Ace Vision’s AnnMarie Hipsley explains why ophthalmology needed a biomechanics advocate with a passion worthy of Erin Brockovich
| Video
sponsored by Ace Vision Group
AnnMarie Hipsley, the Founder and CEO of Ace Vision Group (AVG), a Delaware, USA- based company developing innovative therapeutics for age-related ocular dysfunctions, talks to The Ophthalmologist about her background and work with AVG, and the company’s short- and long-term goals.
She explains how the Group has utilized artificial intelligence and virtual reality platforms to develop the Next Gen VisioLite laser, paints a broad picture of the current gaps in available treatment models for age-related eye diseases, such as presbyopia, and goes into detail about how Laser Scleral Microporation Therapeutic Laser Rejuvenation (LSM) eye therapy sits within the future landscape of treatments for these disorders.
